Seven years of treatment with tenofovir df for chronic hepatitis b virus infection is safe and well tolerated and associated with sustained virological, biochemical and serological responses with no detectable resistance

Marcellin, PatrickGane, Edward J.Tsai, NaokyFlisiak, RobertPetersen, JoergKotzev, Iskren A.Flaherty, John F.Dinh, PhillipGaggar, AnujKitrinos, Kathryn M.Subramanian, ManiMcHutchison, John G.George, JacobButi, Maria2024-08-162024-08-162013-10-010270-9139https://hdl.handle.net/11452/44127eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineGastroenterology & hepatologySeven years of treatment with tenofovir df for chronic hepatitis b virus infection is safe and well tolerated and associated with sustained virological, biochemical and serological responses with no detectable resistanceMeeting Abstract000330252203094649A649A58Supplement1, Special IssueSI